Get trade alerts

Apogee Therapeutics ($APGE) Insider Trading & Smart Money Activity

Apogee Therapeutics, Inc. · Biotechnology · Latest filing Jun 24, 2026

Apogee Therapeutics, Inc. ($APGE) has 1 insider trade, 15 13F position changes and 6 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($3.50M), net -$3.50M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$3.50M
Congress trades (12 mo)
0
13F moves on file
15
Analyst ratings on file
6

APGE insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $3.50M 0 / 0 10 / 5
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All APGE insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Stifel Lowers to hold PT $135 Read
Analyst Mizuho Lowers to hold PT $135 Read
Analyst UBS Lowers to hold PT $135.11 Read
Analyst Deutsche Bank Lowers to hold PT $135 Read
Analyst Citigroup Lowers to hold PT $135 Read
Insider Carl DambkowskiChief Medical Officer Sell (Open-market sale) 10b5-1 26.40K sh $3.50M Read
Analyst Canaccord Genuity Lowers to hold PT $135.11 Read
13F T. Rowe Price Investment Management Added +7.57M sh $1.37B 0.0%+6.2% —
13F T. Rowe Price Investment Management Added +7.57M sh $921.94M 0.0%+6.2% —
13F Rtw Investments Added +70K sh $369.27M 0.0%+6.2% Read
13F Mercer Global Advisors Reduced -59.24K sh $110.36M 0.0%+6.2% —
13F Mercer Global Advisors Reduced -59.24K sh $74.41M 0.0%+6.2% —
13F Janus Henderson Group Added +297.99K sh $313.32M 0.0%+6.2% —
13F Janus Henderson Group Added +297.99K sh $211.27M 0.0%+6.2% —
13F FMR Added +1.04M sh $1.23B 0.0%+6.2% Read
13F FMR Added +1.04M sh $828.98M 0.0%+6.2% —
13F Driehaus Capital Management Reduced -262.90K sh $254.95M 0.0%+6.2% Read
13F Balyasny Asset Management L.P. New +438.65K sh $58.21M 0.0%+6.2% Read
13F Avoro Capital Advisors Sold out -500K sh 0.0%+6.2% Read
13F Alliancebernstein L.P. Reduced -103.36K sh $131.44M 0.0%+6.2% Read
13F Simplex Trading Added +15.01K sh $10.33M -1.8%+2.7% —
13F Simplex Trading Added +15.01K sh $6.96M -1.8%+2.7% —

1W / 1M / 6M = how APGE moved from the trade or filing date.

Insider trading in APGE: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Carl Dambkowski Chief Medical Officer 1 -$3.50M Jun 22, 2026

Institutions moving APGE (13F)

Analyst ratings on APGE

DateFirmActionRatingPrice target1W1M6MStory
Stifel Lowers hold $135 Read
Mizuho Lowers hold $135 Read
UBS Lowers hold $135.11 Read
Deutsche Bank Lowers hold $135 Read
Citigroup Lowers hold $135 Read
Canaccord Genuity Lowers hold $135.11 Read

Frequently asked questions

Are APGE insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $3.50M, a net -$3.50M.

What is the latest insider trade in APGE?

Carl Dambkowski, Chief Medical Officer filed a sell (open-market sale) of 26.40K sh worth $3.50M on Jun 22, 2026.

Which institutions changed their APGE positions?

Recent 13F filers moving the stock include T. Rowe Price Investment Management, Mercer Global Advisors, Janus Henderson Group, FMR and Simplex Trading.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text